Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Mosaic ImmunoEngineering Inc. (CPMV) had Debt to Equity Ratio of -0.22 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.18M |
|
-- |
|
-- |
|
$0.16M |
|
$-0.16M |
|
$-0.02M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.16M |
|
$-0.16M |
|
7.24M |
|
7.24M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$6.33M |
|
$1.50M |
|
$1.50M |
|
$7.83M |
|
$-7.83M |
|
$-7.83M |
|
$-7.83M |
|
7.24M |
|
| Cash Flow Statement Financials | |
$-0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-0.24 |
|
|
Debt to Equity Ratio |
-0.22 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.27% |
|
2.27% |
|
-5414.77% |
|
2.81% |
|
$-1.08 |
|
$-0.00 |
|
$-0.00 |
|